Johnson & Johnson reports Q1 2026 results, raises 2026 outlook

Key Takeaway: Johnson & Johnson has reported its Q1 2026 financial results and has raised its outlook for the year. The details of the results and the specific reasons for the revised outlook were not provided in the article. This update reflects the company's ongoing performance and strategic adjustments in the biopharma sector.